Zug, Switzerland-based vVardis, a dental technology company, has closed on a $50 million funding round.
The funding round builds on the $35 million investment the company received from OrbiMed in February.
The funding will support the growth of the Curodont brand, vVardis’ drill-free tooth decay treatment, according to a July 15 news release.
